MARQUETTE — Dr. Conway McLean has available for patients the Erchonia Lunula laser which targets onychomycosis, also known as nail fungus. This FDA-approved non-invasive laser targets the fungus and stimulates an average of 6.1 mm of new clear nail growth at six months.

“Onychomycosis is a widespread condition which has been classified by the CDC as epidemic. It currently affects approximately 10 percent of the world’s population. The Erchonia laser is an ideal method of treatment because it offers effective, pain-free, non-thermal treatment without side effects. All previous lasers used heat in an attempt to kill the fungal organism and had a poor success rate. The Erchonia laser has been used in several clinical trials, with 89 percent of patients responding to treatment,” said Dr. McLean.